These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5052097)

  • 1. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 5. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanate and sickle-cell disease.
    Cerami A; Peterson CM
    Sci Am; 1975 Apr; 232(4):44-50. PubMed ID: 1114310
    [No Abstract]   [Full Text] [Related]  

  • 7. Urea, cyanate and sickling.
    Harris A
    N Engl J Med; 1971 Sep; 285(12):690-1. PubMed ID: 5563487
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyanate effect on sickling.
    Charache S; Milner PF
    N Engl J Med; 1972 Dec; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract]   [Full Text] [Related]  

  • 9. Sickling reversed and blocked by urea in invert sugar.
    Nalbandian RM; Henry RL; Barnhart MI; Nichols BM; Camp FR; Wolf PL
    Am J Pathol; 1971 Aug; 64(2):405-22. PubMed ID: 5142273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 11. Red cell survival of cyanate reacted sickle cells.
    Bellingham AJ; May A; Huehns ER
    Clin Sci; 1972 Apr; 42(4):21P. PubMed ID: 5020279
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyanate and sickling.
    Charache S; Diederich D
    N Engl J Med; 1971 Nov; 285(20):1147. PubMed ID: 5095746
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickling, urea and cyanate.
    Nalbandian RM
    N Engl J Med; 1972 Feb; 286(7):378-9. PubMed ID: 5008568
    [No Abstract]   [Full Text] [Related]  

  • 17. Viscosity and gelation studies in deer hunting hemoglobins.
    Wong SC; Huisman TH
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):581-4. PubMed ID: 1208578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of sickle-cell disease.
    Lancet; 1972 Mar; 1(7752):671-2. PubMed ID: 4125168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.